Stock Analysis
Xinjiang Tianye Water Saving Irrigation System Full Year 2023 Earnings: CN¥0.02 loss per share (vs CN¥0.15 loss in FY 2022)
Xinjiang Tianye Water Saving Irrigation System (HKG:840) Full Year 2023 Results
Key Financial Results
- Revenue: CN¥2.22b (up 54% from FY 2022).
- Net loss: CN¥11.6m (loss narrowed by 85% from FY 2022).
- CN¥0.02 loss per share (improved from CN¥0.15 loss in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Xinjiang Tianye Water Saving Irrigation System's share price is broadly unchanged from a week ago.
Risk Analysis
It's still necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with Xinjiang Tianye Water Saving Irrigation System, and understanding them should be part of your investment process.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:840
Xinjiang Tianye Water Saving Irrigation System
Designs, manufactures, and sells drip tapes, PVC/PE pipelines, and drip assemblies for use in agricultural water saving irrigation systems in the People's Republic of China.